# Myopathy With Exercise‐Induced Intolerance due to Novel Biallelic Variants in OBSCN—A Clinical, Morphological and Molecular Analysis

**Authors:** Heidrun H. Krämer‐Best, Marlen C. Reis, Andreas Hentschel, Michaela Weiß, Alexander Schaiter, Klaus‐Dieter Böhm, Andreas Roos, Dagmar Nolte, Anne Schänzer

PMC · DOI: 10.1111/nan.70065 · Neuropathology and Applied Neurobiology · 2026-02-05

## TL;DR

A new muscle disorder caused by OBSCN gene variants leads to exercise intolerance and is linked to disrupted calcium handling and cytoskeletal proteins.

## Contribution

Identifies two novel OBSCN variants and links them to dysregulated proteins affecting calcium and cytoskeletal integrity in skeletal muscle.

## Key findings

- OBSCN variants cause exercise intolerance with symptoms like myalgia and rhabdomyolysis.
- Proteomic analysis shows dysregulated proteins related to Ca2+ handling and cytoskeleton in affected muscle.
- Molecular findings highlight obscurin's critical role in skeletal muscle function and autophagy.

## Abstract

The phenotype of OBSCN variants consists of exercise intolerance ranging from myalgia and cramps to rhabdomyolysis. The symptoms are mainly induced by high‐intensity sports.Two previously undescribed OBSCN variants have been identified as being associated with exercise intolerance, myotonic discharges and core‐like lesions in the muscle biopsy.Proteomic analysis of skeletal muscle reveals that the pathogenicity of the OBSCN variants is associated with dysregulated proteins that control Ca2+ handling and the extrasarcomeric cytoskeleton.

The phenotype of OBSCN variants consists of exercise intolerance ranging from myalgia and cramps to rhabdomyolysis. The symptoms are mainly induced by high‐intensity sports.

Two previously undescribed OBSCN variants have been identified as being associated with exercise intolerance, myotonic discharges and core‐like lesions in the muscle biopsy.

Proteomic analysis of skeletal muscle reveals that the pathogenicity of the OBSCN variants is associated with dysregulated proteins that control Ca2+ handling and the extrasarcomeric cytoskeleton.

The phenotype of OBSCN variants consists of exercise intolerance ranging from myalgia and cramps to rhabdomyolysis. Symptoms are mainly induced by high‐intensity sports. Molecular analysis showing a deregulation of muscle processes associated with Ca2+ regulation, extrasarcolemmal integrity and autophagy emphasised the critical role of obscurin in skeletal muscle function.

## Linked entities

- **Genes:** OBSCN (obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF) [NCBI Gene 84033]
- **Proteins:** Obscurin (Obscurin), CA2 (carbonic anhydrase 2)
- **Diseases:** myopathy (MONDO:0005336), rhabdomyolysis (MONDO:0005290)

## Full-text entities

- **Genes:** CSN1S1 (casein alpha s1) [NCBI Gene 1446] {aka CASA, CSN1}, HSPB8 (heat shock protein family B (small) member 8) [NCBI Gene 26353] {aka CMT2L, DHMN2, E2IG1, H11, HMN2, HMN2A}, BAG3 (BAG cochaperone 3) [NCBI Gene 9531] {aka BAG-3, BIS, CAIR-1, CMD1HH, CMT2JJ, HMND15}, ANK1 (ankyrin 1) [NCBI Gene 286] {aka ANK, SPH1, SPH2, ankyrin-1}, OBSCN (obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF) [NCBI Gene 84033] {aka ARHGEF30, RHABDO1, UNC89}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, CAV3 (caveolin 3) [NCBI Gene 859] {aka LGMD1C, LQT9, MPDT, RMD2, VIP-21, VIP21}, XIRP2 (xin actin binding repeat containing 2) [NCBI Gene 129446] {aka CMYA3}, TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, CAPN3 (calpain 3) [NCBI Gene 825] {aka CANP3, CANPL3, LGMD2, LGMD2A, LGMDD4, LGMDR1}, DYSF (dysferlin) [NCBI Gene 8291] {aka FER1L1, LGMD2B, LGMDR2, MMD1}, XIRP1 (xin actin binding repeat containing 1) [NCBI Gene 165904] {aka CMYA1, Xin}, ANK2 (ankyrin 2) [NCBI Gene 287] {aka ANK-2, CFAP87, FAP87, LQT4, brank-2}
- **Diseases:** heart failure (MESH:D006333), muscle weakness (MESH:D018908), oedema (MESH:C536897), hypertrophic muscles (MESH:D019042), hypertrophic (MESH:D002312), obscurin deficiency (MESH:D007153), exercise intolerance (MESH:C564972), necrotic (MESH:D009336), Prolonged muscle contraction (MESH:D008133), pain (MESH:D010146), Myotonic (MESH:D020967), intolerance (MESH:D005633), myotonic discharges (MESH:D019522), myalgia (MESH:D063806), rhabdomyolysis (MESH:D012206), Myopathy (MESH:D009135), stiffness (MESH:C566112), fatty replacement (MESH:D008067), cramping (MESH:D009120), DCM (MESH:D002311)
- **Chemicals:** NADH (MESH:D009243), calcium (MESH:D002118), Ca2+ (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Arg4444Trp, Arg4344Gln, c.8724_8725del, p.Arg4856His, stop codon at position 2911, p.Ala2430Val, p.Ala4864Asp, p.Gly2909Alafs

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12877425/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12877425/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12877425/full.md

---
Source: https://tomesphere.com/paper/PMC12877425